Reporting from: – 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, June 5-8, 2004 – New England Journal of Medicine – Journal of Clinical Oncology ̵
Reporting from:
– 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, June 5-8, 2004
– New England Journal of Medicine
– Journal of Clinical Oncology
– European Journal of Cancer
– Science
– PNAS
In this edition:
Articles in the New England Journal of Medicine on metastatic colorectal cancer are reviewed by George Canellos, who discusses treatment with bevacizumab combined with an irinotecan regimen. Robert Mayer comments on the prospects for developing combinations of targeted therapies for colorectal cancer.
John Hainsworth presented his results at the ASCO conference on treatment of patients with advanced renal cancer with two targeted therapies combined: elotinib and bevacizumab.
The superiority of exemestane over tamoxifen for metastatic breast cancer
was claimed by Robert Paridaens during the New Orleans Meeting in the light of his phase III study findings.
Michele Saunders discusses her New England Journal editorial about two studies in which cisplatin has been added to radiotherapy for treating patients with head and neck cancer.
…